Riskpilot← Back to searchSign inGet full accessInfibra AB
ABActiveOrg 5567330286Industrivägen 8Wholesale of other intermediate products · NACE 4686Est. 20075 employees
Revenue 2025
SEK 8,3M
-5% vs 2024
EBITDA margin
2.7%
-59% vs 2024
Equity ratio
23.4%
Financial strength
Net profit 2025
SEK 42K
-83% vs 2024
| Revenue | SEK 8,3M | -5% |
| EBITDA | SEK 228K | -59% |
| Net profit | SEK 42K | -83% |
| Total assets | SEK 3,4M | -10% |
| Equity | SEK 791K | -20% |
| Employees | 5 | — |
Legal name
Infibra AB
Org number
5567330286
Legal form
Aktiebolag
NACE code
4686 · Wholesale of other intermediate products
Founded
2 juli 2007
Share capital
SEK 100 000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget ska handla med fibersprodukter samt bedriva handel och förvaltning av värdepapper samt därmed förenlig verksamhet.
Address
Industrivägen 8
Phone
+4631534370
Email
peter@infibra.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 8 252 | 8 714 | 8 704 | 8 739 | 8 322 |
| Staff expenses | — | — | — | −2 601 | −2 877 |
| EBITDA | 379 | 16 | 280 | 553 | 228 |
| Depreciation & amort. | −129 | −69 | −68 | −82 | −39 |
| EBIT | 250 | −53 | 212 | 471 | 189 |
| Net financials | −101 | −147 | −155 | −176 | −128 |
| Profit before tax | 148 | −200 | 57 | 295 | 60 |
| Tax | −34 | −0 | −0 | −47 | −19 |
| Net profit | 114 | −200 | 57 | 248 | 42 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 678 | 3 509 | 3 835 | 3 750 | 3 383 |
| Equity | 885 | 685 | 742 | 990 | 791 |
| Long-term debt | 385 | 685 | 421 | 593 | 667 |
| Short-term debt | 2 408 | 2 138 | 2 672 | 2 167 | 1 925 |
| Total debt | 2 793 | 2 823 | 3 093 | 2 760 | 2 592 |
EBITDA margin
2.7%
This company
15.8%
Market median
-83% vs market
20212025
Equity ratio
23.4%
This company
38.2%
Market median
-39% vs market
20212025
Return on equity
5.2%
This company
18.4%
Market median
-72% vs market
20212025
Net profit margin
0.5%
This company
8.1%
Market median
-94% vs market
20212025
Asset turnover
2.46×
This company
1.12×
Market median
+120% vs market
20212025
Debt / equity
3.27×
This company
0.62×
Market median
-427% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
EC | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2022 | |
| Chairman | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Infibra AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eva Chris Nettervik Carlsson | Audit | 0 companies |
| Anna Therese Dellheden | Deputy Board Member | 0 companies |
| Lars Peter Toivola | Chairman | 0 companies |
| Rolf Patrick Hasling | Board of Directors | 0 companies |